Kun Tian

Andrology Department, Sichuan University

Affiliated withSichuan University

Research Area

Biography

Kun Tian has not added Biography.
If you are Kun Tian and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
[The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology\| PubMed ID: 15774155	2005
[Relationship of the disturbed balance between matrix metalloproteinases and their tissue inhibitors and the invasion of malignant salivary gland tumours]. Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology\| PubMed ID: 16178181	2005
[The role of matrix metalloproteinases and their tissue inhibitors in oral lichen planus]. Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology\| PubMed ID: 17067460	2006
MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus. Head & neck\| PubMed ID: 18642282	2008
A comprehensive profiling of supragingival bacterial composition in Chinese twin children and their mothers. Antonie van Leeuwenhoek\| PubMed ID: 28120199	2017
[Analysis of Periodontal Status and Salivary Microbial Diversity in Patients with Rheumatoid Arthritis]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition\| PubMed ID: 31880128	2019
Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysis. Lung cancer (Amsterdam, Netherlands)\| PubMed ID: 32512272	2020
Psychological Impact of the COVID-19 Outbreak on Nurses in China: A Nationwide Survey During the Outbreak. Frontiers in psychiatry\| PubMed ID: 33362609	2020
Cost-Effectiveness of Ribociclib for Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer. Cancer management and research\| PubMed ID: 33364838	2020
Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis. Oral oncology\| PubMed ID: 35428025	2022
Pembrolizumab with or without chemotherapy versus cetuximab plus chemotherapy to treat recurrent or metastatic head and neck squamous cell carcinoma: An updated KEYNOTE-048 based cost-effect... Oral oncology\| PubMed ID: 35483156	2022
Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Frontiers in oncology\| PubMed ID: 36176384	2022
Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal ... Frontiers in public health\| PubMed ID: 36777769	2022
First-line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta-analysis and cost-effectiveness analysis. Head & neck\| PubMed ID: 37435624	2023
CDK4/6 Inhibitors in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: An Updated Network Meta-Analysis and Cost-Effectiveness Analysis. Cancers\| PubMed ID: 37444496	2023
Case report: remedial microdissection testicular sperm extraction after onco-microdissection testicular sperm extraction failure. Medicine\| PubMed ID: 38394502	2024
Stabilizing hexagonally close-packed phase in single-component block copolymers through rational symmetry breaking. Nature communications\| PubMed ID: 39097587	2024